Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest stories Story 10 Feb 2025 Driving innovation forward: UCB unveils new R&D facility Read More Story 9 Jan 2025 UCB and Ailux Biologics Join Forces to Transform Biologics Research Read More Story 6 Dec 2024 What does the future look like for rare genetic epilepsies? Read More Latest press releases The press releases are intended for media and financial analysts Press release 12 Feb 2025 BIMZELX[®]▼(bimekizumab) two-year data at EHSF 2025 demonstrate sustained disease control in... Read More Press release 31 Jan 2025 RYSTIGGO[®]▼(rozanolixizumab), for generalized myasthenia gravis (gMG), receives EU approval for two... Read More Press release 15 Jan 2025 UCB showcases decade of growth and Patient Value Strategy driving differentiated innovation Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Press release 12 Feb 2025 BIMZELX[®]▼(bimekizumab) two-year data at EHSF 2025 demonstrate sustained disease control in... Read More
Press release 31 Jan 2025 RYSTIGGO[®]▼(rozanolixizumab), for generalized myasthenia gravis (gMG), receives EU approval for two... Read More
Press release 15 Jan 2025 UCB showcases decade of growth and Patient Value Strategy driving differentiated innovation Read More
